These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19836467)

  • 1. Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines.
    Ebrahimnejad P; Dinarvand R; Sajadi A; Jaafari MR; Nomani AR; Azizi E; Rad-Malekshahi M; Atyabi F
    Nanomedicine; 2010 Jun; 6(3):478-85. PubMed ID: 19836467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.
    Esmaeili F; Ghahremani MH; Ostad SN; Atyabi F; Seyedabadi M; Malekshahi MR; Amini M; Dinarvand R
    J Drug Target; 2008 Jun; 16(5):415-23. PubMed ID: 18569286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38.
    Ebrahimnejad P; Dinarvand R; Jafari MR; Tabasi SA; Atyabi F
    Int J Pharm; 2011 Mar; 406(1-2):122-7. PubMed ID: 21185365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
    Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
    Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38.
    Ebrahimnejad P; Dinarvand R; Sajadi SA; Atyabi F; Ramezani F; Jaafari MR
    PDA J Pharm Sci Technol; 2009; 63(6):512-20. PubMed ID: 20169857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
    Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
    Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
    Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q
    ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
    Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
    Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
    Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
    J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.
    Vangara KK; Liu JL; Palakurthi S
    Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SN-38 active loading in poly(lactic-co-glycolic acid) nanoparticles and assessment of their anticancer properties on COLO-205 human colon adenocarcinoma cells.
    Essa S; Daoud J; Lafleur M; Martel S; Tabrizian M
    J Microencapsul; 2015; 32(8):784-93. PubMed ID: 26381056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
    Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
    El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
    Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
    Avgoustakis K
    Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered PLGA Core-Lipid Shell Hybrid Nanocarriers Improve the Efficacy and Safety of Irinotecan to Combat Colon Cancer.
    Giram PS; Nimma R; Bulbule A; Yadav AS; Gorain M; Venkata Radharani NN; Kundu GC; Garnaik B
    ACS Biomater Sci Eng; 2024 Oct; 10(10):6661-6676. PubMed ID: 39269431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapy.
    Mehdizadeh M; Rouhani H; Sepehri N; Varshochian R; Ghahremani MH; Amini M; Gharghabi M; Ostad SN; Atyabi F; Baharian A; Dinarvand R
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):495-504. PubMed ID: 27137460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
    Saxena V; Naguib Y; Hussain MD
    Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles.
    Valencia PM; Hanewich-Hollatz MH; Gao W; Karim F; Langer R; Karnik R; Farokhzad OC
    Biomaterials; 2011 Sep; 32(26):6226-33. PubMed ID: 21658757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.